Cetyl Alcohol

Cetyl Alcohol

SCHEMBL753660

CC(C)OC(=O)CCCCC(=O)OC(C)C.CCCCCCCCCCCCCCCCO

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.85
MAPT P10636 2/20 0.62
MAPK1 P28482 1/20 0.62
ALDH1A1 P00352 2/20 0.54
PRKCA P17252 1/20 0.54
PRKCE Q02156 1/20 0.54
PRKCQ Q04759 1/20 0.54
PRKCD Q05655 1/20 0.54
DGKA P23743 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
KDM4E B2RXH2 1/20 0.49
DUSP3 P51452 1/20 0.49
HSD17B10 Q99714 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropyl Palmitate SCHEMBL28114116 1.00 LMNA (0.85) LMNAMAPTMAPK1ALDH1A1PRKCA
Docosanol SCHEMBL27460857 1.00 LMNA (0.85) LMNAMAPTMAPK1ALDH1A1PRKCA
Isopropyl Palmitate SCHEMBL14480098 1.00 LMNA (0.85) LMNAMAPTMAPK1ALDH1A1PRKCA
Isopropyl Myristate SCHEMBL28840928 1.00 LMNA (0.85) LMNAMAPTMAPK1ALDH1A1PRKCA
Isopropyl Myristate SCHEMBL26969553 1.00 LMNA (0.85) LMNAMAPTMAPK1ALDH1A1PRKCA
Isopropyl Palmitate SCHEMBL11589658 1.00 LMNA (0.85) LMNAMAPTMAPK1ALDH1A1PRKCA
Isopropyl Myristate SCHEMBL5513841 1.00 LMNA (0.85) LMNAMAPTMAPK1ALDH1A1PRKCA
Isopropyl Myristate SCHEMBL10382139 1.00 LMNA (0.85) LMNAMAPTMAPK1ALDH1A1PRKCA
Isopropyl Myristate SCHEMBL10717490 1.00 LMNA (0.85) LMNAMAPTMAPK1ALDH1A1PRKCA
Isopropyl Myristate SCHEMBL26969550 1.00 LMNA (0.85) LMNAMAPTMAPK1ALDH1A1PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1885769-B1 NOVEL POLYSILOXANE SUNSCREENS DSM IP ASSETS BV (NL) 2013-08-28 EP disclosed
EP-1899015-B1 COMPOSITION WITH TIGHT CAPSULES CONTAINING A SUNSCREEN AGENT DSM IP ASSETS BV (NL) 2012-03-21 EP disclosed
US-7906108-B2 Polysiloxane sunscreens DSM IP ASSETS B.V. (NL) 2011-03-15 US disclosed
EP-2247280-A1 FILM FORMING PERSONAL CARE COMPOSITIONS The Procter & Gamble Company (US) 2010-11-10 EP disclosed
US-20100021409-A1 Film Forming Personal Care Compositions THE PROCTER & GAMBLE COMPANY 2010-01-28 US disclosed
EP-1521798-B1 SUNSCREENS DSM IP ASSETS BV (NL) 2010-01-27 EP disclosed
US-20100008883-A1 FILM FORMING PERSONAL CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2010-01-14 US disclosed
WO-2009101583-A1 FILM FORMING PERSONAL CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2009-08-20 WO disclosed
US-20090068127-A1 Novel Polysiloxane Sunscreens DSM IP ASSETS B.V. (NL) 2009-03-12 US disclosed
US-20080199526-A1 Composition With Tight Capsules Containing a Sunscreen Agent DSM IP ASSETS B.V. (NL) 2008-08-21 US disclosed
WO-2006128614-A1 NOVEL POLYSILOXANE SUNSCREENS DSM IP ASSETS B.V. (NL) 2006-12-07 WO disclosed
US-20060160976-A1 Sunscreens DSM IP ASSETS B.V. (NL) 2006-07-20 US disclosed
US-20050260144-A1 Benzoxazole and benzodiazole uv-a sunscreens DSM IP ASSETS B.V. (NL) 2005-11-24 US disclosed
EP-1423448-A4 POLYMERIC URETHANE ESTER QUATS AND THEIR USE IN PERSONAL CARE COMPOSITIONS ALZO INT INC (US) 2005-06-29 EP disclosed
EP-1521798-A1 SUNSCREENS DSM IP Assets B.V. (NL) 2005-04-13 EP disclosed
EP-1515694-A1 BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS DSM IP Assets B.V. (NL) 2005-03-23 EP disclosed
EP-1423448-A2 POLYMERIC URETHANE ESTER QUATS AND THEIR USE IN PERSONAL CARE COMPOSITIONS Alzo International, Inc. (US) 2004-06-02 EP disclosed
WO-2004007592-A1 SUNSCREENS DSM IP ASSETS B.V. (NL) 2004-01-22 WO disclosed
WO-2004000256-A1 BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS DSM IP ASSETS B.V. (NL) 2003-12-31 WO disclosed
WO-2003016247-A2 POLYMERIC URETHANE ESTER QUATS AND THEIR USE IN PERSONAL CARE COMPOSITIONS ALZO INTERNATIONAL, INC. (US) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090068127-A1 Novel Polysiloxane Sunscreens ERCC4, ERCC1, RAD54L LMNA 1407/4885MAPT 1029/4885MAPK1 3750/4885
US-20080199526-A1 Composition With Tight Capsules Containing a Sunscreen Agent SUN2, DSG1, DSC1 LMNA 1211/4885MAPT 544/4885MAPK1 4832/4885
US-20050260144-A1 Benzoxazole and benzodiazole uv-a sunscreens SUN2, CYP27B1, ERCC4 LMNA 904/4885MAPT 543/4885MAPK1 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.